semaglutide patent expiration semaglutide patent expiry date The Heavy Price of GLP-1 Drugs – I-MAK Growing concerns over semaglutide weight

CONTENTS Intro: Hyperammonemia is a serial killer Clinical presentation & diagnosis Causes Investigation & monitoring Management [1] Neurocritical care of hyperammonemia [2] Reduced enteral ammonia absorption [3] Basic nutritional manipulations [4] Discontinue potentially offensive medications [5] Consider treatment for infectious etiologies [6] Consider zinc supplementation [7] Consider carnitine supplementation [8] Consider additional vitamins [9] Consider L-arginine administration [10] Support renal clearance & consider CRRT [11] Sodium phenylacetate plus sodium benzoate (Ammonul) hyperammonemia is a serial killer hyperammonemia is a serial killer Nonhepatic hyperammonemia behaves like a serial killer

A diet that is lower in fats and high in fiber can help ease these side effects

Because semaglutide reduced the risk of MACE irrespective of baseline kidney function and damage, it is of interest to evaluate if semaglutide can provide consistent effects on hard kidney-related outcomes (kidney failure, 50% decline in eGFR from baseline, or CV or kidney-related death) in the FLOW trial

If you meet any of the following criteria, you may not be eligible for a prescription of GLP-1 weight loss medication: 1